{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:57:30Z","timestamp":1781067450331,"version":"3.54.1"},"reference-count":63,"publisher":"Bentham Science Publishers Ltd.","issue":"6","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>There is an urgent need to develop effective antiviral treatments against SARS-CoV-2.\nDespite the availability of vaccines, drug discovery remains critical for combating emerging variants.\nMolecular docking studies have become a vital computational tool for identifying antiviral\ndrugs capable of inhibiting different SARS-CoV-2 proteins. This review explores the role of metal\ncomplexes as promising viral inhibitors through in silico molecular docking approaches. The binding\nabilities of several coordination complexes derived from iron, copper, palladium, and zinc ions\nhave been evaluated against major viral proteins such as the spike glycoprotein, RNA-dependent\nRNA polymerase (RdRp), and the main protease (Mpro), which are responsible for viral infection.\nComparative docking studies of specific metal-based compounds with conventional antiviral drugs\nhighlight their superior binding affinities and inhibitory potential. Furthermore, ADME (Absorption,\nDistribution, Metabolism, and Excretion) analyses, molecular dynamics simulations, and drugdelivery\nstrategies are discussed to assess pharmacokinetics and therapeutic viability. Overall, this\nreview emphasizes the importance of molecular docking in the rational design of metal complexes\nas antiviral agents and its relevance for developing effective therapeutic strategies to combat\nCOVID-19.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113895575407844251125060503","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T20:21:06Z","timestamp":1769890866000},"page":"399-411","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Mini Review on Metal Complexes as Potential Anti-SARS-CoV-2 Agents: Insights from Molecular Docking Studies"],"prefix":"10.2174","volume":"26","author":[{"given":"Endamuri Sai","family":"Vineeth","sequence":"first","affiliation":[{"name":"FBBiologie, Chemie, Pharmazie, Institut f\u00fcr Chemie und Biochemie, Freie Universt\u00e4t Berlin, Berlin, 14195, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smit","family":"Saha","sequence":"additional","affiliation":[{"name":"Department of Chemistry, National Institute of Technology Agartala, Jirania, Agartala, 799046, Tripura, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata Bharat","family":"Nishtala","sequence":"additional","affiliation":[{"name":"Department of Chemistry, National Institute of Technology Agartala, Jirania, Agartala, 799046, Tripura, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","year":"2020","unstructured":"Organization, WHO director-general opening remarks at the member state briefing on the COVID-19 pandemic evaluation.  Available from:  https:\/\/www.who.int\/dg\/speeches\/detail\/who-director-general-opening-remarks-at-the-member-state-briefing-on-the-covid-19-pandemic-evaluation-09-july-2020"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijsu.2020.04.018","volume":"78","author":"Nicola M.","year":"2020","unstructured":"Nicola M.; Alsafi Z.; Sohrabi C.; Kerwan A.; Al-Jabir A.; Iosifidis C.; Agha M.; Agha R.; The socio-economic implications of the coronavirus pandemic (COVID-19): A review. Int J Surg  2020,78,185-193","journal-title":"Int J Surg"},{"key":"ref=3","unstructured":"Organization, Weekly operational update on COVID-19.  Available from:  https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/situation-reports\/wou-28-august-approved.pdf?sfvrsn=d9e49c20_2"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/S1473-3099(20)30482-5","volume":"20","author":"Tabata S.","year":"2020","unstructured":"Tabata S.; Imai K.; Kawano S.; Ikeda M.; Kodama T.; Miyoshi K.; Obinata H.; Mimura S.; Kodera T.; Kitagaki M.; Sato M.; Suzuki S.; Ito T.; Uwabe Y.; Tamura K.; Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: A retrospective analysis. Lancet Infect Dis  2020,20(9),1043-1050","journal-title":"Lancet Infect Dis"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/s41591-020-0965-6","volume":"26","author":"Long Q.X.","year":"2020","unstructured":"Long Q.X.; Tang X.J.; Shi Q.L.; Li Q.; Deng H.J.; Yuan J.; Hu J.L.; Xu W.; Zhang Y.; Lv F.J.; Su K.; Zhang F.; Gong J.; Wu B.; Liu X.M.; Li J.J.; Qiu J.F.; Chen J.; Huang A.L.; Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med  2020,26(8),1200-1204","journal-title":"Nat Med"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ijid.2020.03.004","volume":"94","author":"Wu D.","year":"2020","unstructured":"Wu D.; Wu T.; Liu Q.; Yang Z.; The SARS-CoV-2 outbreak: What we know. Int J Infect Dis  2020,94,44-48","journal-title":"Int J Infect Dis"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1002\/jmv.25822","volume":"92","author":"Cao Y.","year":"2020","unstructured":"Cao Y.; Liu X.; Xiong L.; Cai K.; Imaging and clinical features of patients with 2019 novel coronavirus SARS\u2010CoV\u20102: A systematic review and meta\u2010analysis. J Med Virol  2020,92(9),1449-1459","journal-title":"J Med Virol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5582\/ddt.2020.03008","volume":"14","year":"2020","unstructured":"(a) Ahsan, W.; Javed, S.; Bratty, M.A.; Alhazmi, H.A.; Najmi, A. Treatment of SARS-CoV-2: How far have we reached? Drug Discov Ther  2020,14(2),67-72","journal-title":"Drug Discov Ther"},{"key":"ref=b","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","volume":"395","author":"Richardson P.","year":"2020","unstructured":"Richardson P.; Griffin I.; Tucker C.; Smith D.; Oechsle O.; Phelan A.; Rawling M.; Savory E.; Stebbing J.; Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet  2020,395(10223),e30-e31","journal-title":"Lancet"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"112647","DOI":"10.1016\/j.ejmech.2020.112647","volume":"203","author":"Kouznetsov V.V.","year":"2020","unstructured":"Kouznetsov V.V.; COVID-19 treatment: Much research and testing, but far, few magic bullets against SARS-CoV-2 coronavirus. Eur J Med Chem  2020,203,112647","journal-title":"Eur J Med Chem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"122859","DOI":"10.1016\/j.lfs.2024.122859","volume":"352","author":"Paudel K.R.","year":"2024","unstructured":"Paudel K.R.; Singh M.; De Rubis G.; Kumbhar P.; Mehndiratta S.; Kokkinis S.; El-Sherkawi T.; Gupta G.; Singh S.K.; Malik M.Z.; Mohammed Y.; Oliver B.G.; Disouza J.; Patravale V.; Hansbro P.M.; Dua K.; Computational and biological approaches in repurposing ribavirin for lung cancer treatment: Unveiling antitumorigenic strategies. Life Sci  2024,352,122859","journal-title":"Life Sci"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"7095","DOI":"10.1128\/JVI.79.11.7095-7103.2005","volume":"79","author":"Chen L.","year":"2005","unstructured":"Chen L.; Gui C.; Luo X.; Yang Q.; G\u00fcnther S.; Scandella E.; Drosten C.; Bai D.; He X.; Ludewig B.; Chen J.; Luo H.; Yang Y.; Yang Y.; Zou J.; Thiel V.; Chen K.; Shen J.; Shen X.; Jiang H.; Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro. J Virol  2005,79(11),7095-7103","journal-title":"J Virol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1021\/acsmedchemlett.2c00531","volume":"14","author":"Tremblay T.","year":"2023","unstructured":"Tremblay T.; Bergeron C.; Gagnon D.; B\u00e9rub\u00e9 C.; Voyer N.; Richard D.; Gigu\u00e8re D.; Squaramide Tethered Clindamycin, Chloroquine, and Mortiamide Hybrids: Design, synthesis, and antimalarial activity. ACS Med Chem Lett  2023,14(2),217-222","journal-title":"ACS Med Chem Lett"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"6503","DOI":"10.1021\/acssuschemeng.2c00570","volume":"10","author":"Van Praet S.","year":"2022","unstructured":"Van Praet S.; Preegel G.; Rammal F.; Sels B.F.; One-pot consecutive reductive amination synthesis of pharmaceuticals: From biobased glycolaldehyde to hydroxychloroquine. ACS Sustain Chemand Eng  2022,10(20),6503-6508","journal-title":"ACS Sustain Chemand Eng"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1021\/acsmedchemlett.3c00048","volume":"14","author":"Sparrow K.J.","year":"2023","unstructured":"Sparrow K.J.; Shrestha R.; Wood J.M.; Clinch K.; Hurst B.L.; Wang H.; Gowen B.B.; Julander J.G.; Tarbet E.B.; McSweeney A.M.; Ward V.K.; Evans G.B.; Harris L.D.; An isomer of Galidesivir that potently inhibits influenza viruses and members of the Bunyavirales order. ACS Med Chem Lett  2023,14(4),506-513","journal-title":"ACS Med Chem Lett"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"11045","DOI":"10.1021\/acs.joc.3c01005","volume":"88","author":"Zdun B.","year":"2023","unstructured":"Zdun B.; Reiter T.; Kroutil W.; Borowiecki P.; Chemoenzymatic synthesis of Tenofovir. J Org Chem  2023,88(15),11045-11055","journal-title":"J Org Chem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1021\/acsinfecdis.5b00029","volume":"1","author":"Chen Z.","year":"2015","unstructured":"Chen Z.; Jochmans D.; Ku T.; Paeshuyse J.; Neyts J.; Seley-Radtke K.L.; Bicyclic and tricyclic \u201cExpanded\u201d nucleobase analogues of Sofosbuvir: New scaffolds for hepatitis C therapies. ACS Infect Dis  2015,1(8),357-366","journal-title":"ACS Infect Dis"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1021\/acsinfecdis.0c00874","volume":"7","author":"Namchuk M.N.","year":"2021","unstructured":"Namchuk M.N.; Early Returns on small molecule therapeutics for SARS-CoV-2. ACS Infect Dis  2021,7(6),1298-1302","journal-title":"ACS Infect Dis"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","volume":"46","author":"Zhang H.","year":"2020","unstructured":"Zhang H.; Penninger J.M.; Li Y.; Zhong N.; Slutsky A.S.; Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med  2020,46(4),586-590","journal-title":"Intensive Care Med"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","volume":"126","author":"Gheblawi M.","year":"2020","unstructured":"Gheblawi M.; Wang K.; Viveiros A.; Nguyen Q.; Zhong J.C.; Turner A.J.; Raizada M.K.; Grant M.B.; Oudit G.Y.; Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system. Circ Res  2020,126(10),1456-1474","journal-title":"Circ Res"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"14614","DOI":"10.1128\/JVI.79.23.14614-14621.2005","volume":"79","author":"Jia H.P.","year":"2005","unstructured":"Jia H.P.; Look D.C.; Shi L.; Hickey M.; Pewe L.; Netland J.; Farzan M.; Wohlford-Lenane C.; Perlman S.; McCray P.B.; ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J Virol  2005,79(23),14614-14621","journal-title":"J Virol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"Hamming I.","year":"2004","unstructured":"Hamming I.; Timens W.; Bulthuis M.L.C.; Lely A.T.; Navis G.J.; van Goor H.; Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol  2004,203(2),631-637","journal-title":"J Pathol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.2353\/ajpath.2007.061088","volume":"170","author":"Gu J.","year":"2007","unstructured":"Gu J.; Korteweg C.; Pathology and pathogenesis of severe acute respiratory syndrome. Am J Pathol  2007,170(4),1136-1147","journal-title":"Am J Pathol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.hjc.2020.05.007","volume":"62","author":"Amirfakhryan H.","year":"2021","unstructured":"Amirfakhryan H.; safari, F. Outbreak of SARS-CoV2: Pathogenesis of infection and cardiovascular involvement. Hellenic J Cardiol  2021,62(1),13-23","journal-title":"Hellenic J Cardiol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.coviro.2012.04.004","volume":"2","author":"Totura A.L.","year":"2012","unstructured":"Totura A.L.; Baric R.S.; SARS coronavirus pathogenesis: Host innate immune responses and viral antagonism of interferon. Curr Opin Virol  2012,2(3),264-275","journal-title":"Curr Opin Virol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"2000607","DOI":"10.1183\/13993003.00607-2020","volume":"55","author":"Mason R.J.","year":"2020","unstructured":"Mason R.J.; Pathogenesis of COVID-19 from a cell biology perspective. Eur Respir J  2020,55(4),2000607","journal-title":"Eur Respir J"},{"key":"ref=26","first-page":"396","volume":"7","author":"Jain A.N.","year":"2004","unstructured":"Jain A.N.; Virtual screening in lead discovery and optimization. Curr Opin Drug Discov Devel  2004,7(4),396-403","journal-title":"Curr Opin Drug Discov Devel"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"128595","DOI":"10.1016\/j.molstruc.2020.128595","volume":"1219","author":"Baildya N.","year":"2020","unstructured":"Baildya N.; Ghosh N.N.; Chattopadhyay A.P.; Inhibitory activity of hydroxychloroquine on COVID-19 main protease: An insight from MD-simulation studies. J Mol Struct  2020,1219,128595","journal-title":"J Mol Struct"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"108448","DOI":"10.1016\/j.clim.2020.108448","volume":"215","author":"Felsenstein S.","year":"2020","unstructured":"Felsenstein S.; Herbert J.A.; McNamara P.S.; Hedrich C.M.; COVID-19: Immunology and treatment options. Clin Immunol  2020,215,108448","journal-title":"Clin Immunol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"6418","DOI":"10.3390\/ijms23126418","volume":"23","author":"Abd El-Lateef H.M.A.","year":"2022","unstructured":"Abd El-Lateef H.M.A.; El-Dabea T.; Khalaf M.M.; Abu-Dief A.M.; Development of metal complexes for treatment of coronaviruses. Int J Mol Sci  2022,23(12),6418","journal-title":"Int J Mol Sci"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1039\/D0NJ04578K","volume":"45","author":"Pal M.","year":"2021","unstructured":"Pal M.; Musib D.; Roy M.; Transition metal complexes as potential tools against SARS-CoV-2: an in silico approach. New J Chem  2021,45(4),1924-1933","journal-title":"New J Chem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"7429","DOI":"10.1002\/slct.202101852","volume":"6","author":"Pal M.","year":"2021","unstructured":"Pal M.; Musib D.; Zade A.J.; Chowdhury N.; Roy M.; Computational studies of selected transition metal complexes as potential drug candidates against the SARS\u2010CoV\u20102 virus. ChemistrySelect  2021,6(29),7429-7435","journal-title":"ChemistrySelect"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"35099","DOI":"10.1039\/D0RA07062A","volume":"10","author":"Milenkovi\u0107 D.A.","year":"2020","unstructured":"Milenkovi\u0107 D.A.; Dimi\u0107 D.S.; Avdovi\u0107 E.H.; Markovi\u0107 Z.S.; Several coumarin derivatives and their Pd(ii) complexes as potential inhibitors of the main protease of SARS-CoV-2, an in silico approach. RSC Advances  2020,10(58),35099-35108","journal-title":"RSC Advances"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"104772","DOI":"10.1016\/j.bioorg.2021.104772","volume":"110","author":"Ali A.","year":"2021","unstructured":"Ali A.; Sepay N.; Afzal M.; Sepay N.; Alarifi A.; Shahid M.; Ahmad M.; Molecular designing, crystal structure determination and in silico screening of copper(II) complexes bearing 8-hydroxyquinoline derivatives as anti-COVID-19. Bioorg Chem  2021,110,104772","journal-title":"Bioorg Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"130961","DOI":"10.1016\/j.molstruc.2021.130961","volume":"1244","author":"Almalki S.A.","year":"2021","unstructured":"Almalki S.A.; Bawazeer T.M.; Asghar B.; Alharbi A.; Aljohani M.M.; Khalifa M.E.; El-Metwaly N.; Synthesis and characterization of new thiazole-based Co(II) and Cu(II) complexes; therapeutic function of thiazole towards COVID-19 in comparing to current antivirals in treatment protocol. J Mol Struct  2021,1244,130961","journal-title":"J Mol Struct"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"117803","DOI":"10.1016\/j.molliq.2021.117803","volume":"345","author":"Alharbi A.","year":"2022","unstructured":"Alharbi A.; Alsoliemy A.; Alzahrani S.O.; Alkhamis K.; Almehmadi S.J.; Khalifa M.E.; Zaky R.; El-Metwaly N.M.; Green synthesis approach for new Schiff\u2019s-base complexes; theoretical and spectral based characterization with in-vitro and in-silico screening. J Mol Liq  2022,345,117803","journal-title":"J Mol Liq"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"131166","DOI":"10.1016\/j.molstruc.2021.131166","volume":"1246","author":"Atasever Arslan B.","year":"2021","unstructured":"Atasever Arslan B.; Kaya, B.; \u015eahin, O.; Baday, S.; Saylan, C.C.; \u00dclk\u00fcseven, B. The iron(III) and nickel(II) complexes with tetradentate thiosemicarbazones. Synthesis, experimental, theoretical characterization, and antiviral effect against SARS-CoV-2. J Mol Struct  2021,1246,131166","journal-title":"J Mol Struct"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"129979","DOI":"10.1016\/j.molstruc.2021.129979","volume":"1231","author":"Hussein R.K.","year":"2021","unstructured":"Hussein R.K.; Elkhair H.M.; Molecular docking identification for the efficacy of some zinc complexes with chloroquine and hydroxychloroquine against main protease of COVID-19. J Mol Struct  2021,1231,129979","journal-title":"J Mol Struct"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"17109","DOI":"10.1021\/acs.inorgchem.0c02373","volume":"59","author":"Haribabu J.","year":"2020","unstructured":"Haribabu J.; Srividya S.; Mahendiran D.; Gayathri D.; Venkatramu V.; Bhuvanesh N.; Karvembu R.; Synthesis of Palladium(II) complexes via michael addition: Antiproliferative effects through ROS-mediated mitochondrial apoptosis and docking with SARS-CoV-2. Inorg Chem  2020,59(23),17109-17122","journal-title":"Inorg Chem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"e7461","DOI":"10.1002\/aoc.7461","volume":"38","author":"Elhusseiny A.F.","year":"2024","unstructured":"Elhusseiny A.F.; Sherif N.M.; Soliman S.M.; Ali A.E.; Elsayed E.H.; A promising perspective through potential antimicrobial, anti\u2010cancer, and antiviral activity against SARS\u2010CoV\u20102 of silver(I) complexes: Synthesis, characterization, density functional theory calculations, and in\u2010silico molecular docking studies. Appl Organomet Chem  2024,38(6),e7461","journal-title":"Appl Organomet Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.1039\/D2NJ00283C","volume":"46","author":"Kumar S.","year":"2022","unstructured":"Kumar S.; Choudhary M.; Synthesis and characterization of novel copper (ii) complexes as potential drug candidates against SARS-CoV-2 main protease. New J Chem  2022,46(10),4911-4926","journal-title":"New J Chem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"7031","DOI":"10.1039\/D3DT00256J","volume":"52","author":"Hajibabaei F.","year":"2023","unstructured":"Hajibabaei F.; Sanei Movafagh S.; Salehzadeh S.; Gable R.W.; A tris(2-aminoethyl)amine-based zinc complex as a highly water-soluble drug carrier for the anti-COVID-19 drug favipiravir: a joint experimental and theoretical study. Dalton Trans  2023,52(21),7031-7047","journal-title":"Dalton Trans"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"117592","DOI":"10.1016\/j.lfs.2020.117592","volume":"253","author":"Elfiky A.A.","year":"2020","unstructured":"Elfiky A.A.; Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study. Life Sci  2020,253,117592","journal-title":"Life Sci"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"4529","DOI":"10.26355\/eurrev_202004_21036","volume":"24","author":"Joshi T.","year":"2020","unstructured":"Joshi T.; Joshi T.; Sharma P.; Mathpal S.; Pundir H.; Bhatt V.; Chandra S.; In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking. Eur Rev Med Pharmacol Sci  2020,24(8),4529-4536","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"5109","DOI":"10.1093\/bioinformatics\/btaa645","volume":"36","author":"Kong R.","year":"2020","unstructured":"Kong R.; Yang G.; Xue R.; Liu M.; Wang F.; Hu J.; Guo X.; Chang S.; COVID-19 Docking Server: a meta server for docking small molecules, peptides and antibodies against potential targets of COVID-19. Bioinformatics  2020,36(20),5109-5111","journal-title":"Bioinformatics"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"107656","DOI":"10.1016\/j.compbiolchem.2022.107656","volume":"98","author":"Bucinsky L.","year":"2022","unstructured":"Bucinsky L.; Bort\u0148\u00e1k D.; Gall M.; Mat\u00fa\u0161ka J.; Milata V.; Pito\u0148\u00e1k, M.; \u0160tekl\u00e1\u010d, M.; V\u00e9gh, D.; Zaja\u010dek, D. Machine learning prediction of 3CL SARS-CoV-2 docking scores. Comput Biol Chem  2022,98,107656","journal-title":"Comput Biol Chem"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1080\/07391102.2020.1758791","volume":"39","author":"Elmezayen A.D.","year":"2021","unstructured":"Elmezayen A.D.; Al-Obaidi A.; \u015eahin A.T.; Yelek\u00e7i K.; Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes. J Biomol Struct Dyn  2021,39(8),2980-2992","journal-title":"J Biomol Struct Dyn"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"5172","DOI":"10.3390\/molecules25215172","volume":"25","author":"Tejera E.","year":"2020","unstructured":"Tejera E.; Munteanu C.R.; L\u00f3pez-Cort\u00e9s A.; Cabrera-Andrade A.; P\u00e9rez-Castillo Y.; Drugs repurposing using QSAR, Docking and molecular dynamics for possible inhibitors of the SARS-CoV-2 Mpro Protease. Molecules  2020,25(21),5172","journal-title":"Molecules"},{"key":"ref=48","doi-asserted-by":"publisher","DOI":"10.26434\/chemrxiv.11871402.v4","author":"Smith M.","year":"2020","unstructured":"Smith M.; Smith J.; Repurposing therapeutics for COVID-19: Supercomputer-based docking to the SARS-CoV-2 viral spike protein and viral spike protein-human ACE2 interface. Chemrxiv  2020","journal-title":"Chemrxiv"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"130968","DOI":"10.1016\/j.molstruc.2021.130968","volume":"1245","author":"\u0160tekl\u00e1\u010d M.","year":"2021","unstructured":"\u0160tekl\u00e1\u010d M.; Zaja\u010dek D.; Bu\u010dinsk\u00fd L.; 3CLpro and PLpro affinity, a docking study to fight COVID19 based on 900 compounds from PubChem and literature. Are there new drugs to be found? J Mol Struct  2021,1245,130968","journal-title":"J Mol Struct"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"5543","DOI":"10.1038\/s41598-021-84700-0","volume":"11","author":"Guedes I.A.","year":"2021","unstructured":"Guedes I.A.; Costa L.S.C.; dos Santos K.B.; Karl A.L.M.; Rocha G.K.; Teixeira I.M.; Galheigo M.M.; Medeiros V.; Krempser E.; Cust\u00f3dio F.L.; Barbosa H.J.C.; Nicol\u00e1s M.F.; Dardenne L.E.; Drug design and repurposing with DockThor-VS web server focusing on SARS-CoV-2 therapeutic targets and their non-synonym variants. Sci Rep  2021,11(1),5543","journal-title":"Sci Rep"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"7058","DOI":"10.1021\/acs.jpclett.0c02278","volume":"11","author":"Batra R.","year":"2020","unstructured":"Batra R.; Chan H.; Kamath G.; Ramprasad R.; Cherukara M.J.; Sankaranarayanan S.K.R.S.; screening of therapeutic agents for COVID-19 using machine learning and ensemble docking studies. J Phys Chem Lett  2020,11(17),7058-7065","journal-title":"J Phys Chem Lett"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"107536","DOI":"10.1016\/j.compbiolchem.2021.107536","volume":"93","author":"El-Behery H.","year":"2021","unstructured":"El-Behery H.; Attia A.F.; El-Fishawy N.; Torkey H.; Efficient machine learning model for predicting drug-target interactions with case study for COVID-19. Comput Biol Chem  2021,93,107536","journal-title":"Comput Biol Chem"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1021\/acs.jctc.8b00908","volume":"15","author":"Sch\u00fctt K.T.","year":"2019","unstructured":"Sch\u00fctt K.T.; Kessel P.; Gastegger M.; Nicoli K.A.; Tkatchenko A.; M\u00fcller K.R.; SchNetPack: A deep learning toolbox for atomistic systems. J Chem Theory Comput  2019,15(1),448-455","journal-title":"J Chem Theory Comput"},{"key":"ref=54","author":"Abadi M.","year":"2016","unstructured":"Abadi M.; Agarwal A.; Barham P.; Brevdo E.; Chen Z.; Citro C.; Corrado G.S.; Davis A.; Dean J.; Devin M.; Ghemawat S.; Goodfellow I.; Harp A.; Irving G.; Isard M.; Jia Y.; Jozefowicz R.; Kaiser L.; Kudlur M.; Levenberg J.; Man\u2019e D.; Monga R.; Moore S.; Murray D.; Olah C.; Schuster M.; Shlens J.; Steiner B.; Sutskever I.; Talwar K.; Tucker P.; Vanhoucke V.; Vasudevan V.; Vi\u2019egas F.; Vinyals O.; Warden P.; Wattenberg M.; Wicke M.; Yu Y.; Zheng X.;  TensorFlow: LargeScale machine learning on heterogeneous systems, software  2016","journal-title":"TensorFlow: LargeScale machine learning on heterogeneous systems, software"},{"key":"ref=55","doi-asserted-by":"publisher","DOI":"10.1145\/2939672.2939785","author":"Chen T.","year":"2016","unstructured":"Chen T.; Guestrin C.; XGBoost: A scalable tree boosting system. Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, KDD \u201916  2016","journal-title":"Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, KDD \u201916"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"2000028","DOI":"10.1002\/minf.202000028","volume":"39","author":"Ton A.T.","year":"2020","unstructured":"Ton A.T.; Gentile F.; Hsing M.; Ban F.; Cherkasov A.; Rapid identification of potential inhibitors of SARS\u2010CoV\u20102 main protease by deep docking of 1.3 billion compounds. Mol Inform  2020,39(8),2000028","journal-title":"Mol Inform"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"6728","DOI":"10.1080\/07391102.2020.1802341","volume":"39","author":"Joshi T.","year":"2021","unstructured":"Joshi T.; Joshi T.; Pundir H.; Sharma P.; Mathpal S.; Chandra S.; Predictive modeling by deep learning, virtual screening and molecular dynamics study of natural compounds against SARS-CoV-2 main protease. J Biomol Struct Dyn  2021,39(17),6728-6746","journal-title":"J Biomol Struct Dyn"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"5832","DOI":"10.1021\/acs.jcim.0c01010","volume":"60","author":"Acharya A.","year":"2020","unstructured":"Acharya A.; Agarwal R.; Baker M.B.; Baudry J.; Bhowmik D.; Boehm S.; Byler K.G.; Chen S.Y.; Coates L.; Cooper C.J.; Demerdash O.; Daidone I.; Eblen J.D.; Ellingson S.; Forli S.; Glaser J.; Gumbart J.C.; Gunnels J.; Hernandez O.; Irle S.; Kneller D.W.; Kovalevsky A.; Larkin J.; Lawrence T.J.; LeGrand S.; Liu S.H.; Mitchell J.C.; Park G.; Parks J.M.; Pavlova A.; Petridis L.; Poole D.; Pouchard L.; Ramanathan A.; Rogers D.M.; Santos-Martins D.; Scheinberg A.; Sedova A.; Shen Y.; Smith J.C.; Smith M.D.; Soto C.; Tsaris A.; Thavappiragasam M.; Tillack A.F.; Vermaas J.V.; Vuong V.Q.; Yin J.; Yoo S.; Zahran M.; Zanetti-Polzi L.; Supercomputer-Based Ensemble Docking Drug Discovery Pipeline with Application to COVID-19. J Chem Inf Model  2020,60(12),5832-5852","journal-title":"J Chem Inf Model"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1126\/science.aat2663","volume":"361","author":"Sanchez-Lengeling B.","year":"2018","unstructured":"Sanchez-Lengeling B.; Aspuru-Guzik A.; Inverse molecular design using machine learning: Generative models for matter engineering. Science  2018,361(6400),360-365","journal-title":"Science"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"6956","DOI":"10.1038\/s41598-025-91235-1","volume":"15","author":"Sinsulpsiri S.","year":"2025","unstructured":"Sinsulpsiri S.; Nishii Y.; Xu-Xu Q.F.; Miura M.; Wilasluck P.; Salamteh K.; Deetanya P.; Wangkanont K.; Suroengrit A.; Boonyasuppayakorn S.; Duan L.; Harada R.; Hengphasatporn K.; Shigeta Y.; Shi L.; Maitarad P.; Rungrotmongkol T.; Unveiling the antiviral inhibitory activity of ebselen and ebsulfur derivatives on SARS-CoV-2 using machine learning-based QSAR, LB-PaCS-MD, and experimental assay. Sci Rep  2025,15(1),6956","journal-title":"Sci Rep"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"4204","DOI":"10.1109\/JBHI.2024.3384333","volume":"28","author":"Cai J.","year":"2024","unstructured":"Cai J.; Li Y.; Liu B.; Wu Z.; Zhu S.; Chen Q.; Lei Q.; Hou H.; Guo Z.; Jiang H.; Guo S.; Wang F.; Huang S.; Zhu S.; Fan X.; Tao S.; Developing deep LSTMs with later temporal attention for predicting COVID-19 severity, clinical outcome, and antibody level by screening serological indicators over time. IEEE J Biomed Health Inform  2024,28(7),4204-4215","journal-title":"IEEE J Biomed Health Inform"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"105264","DOI":"10.1016\/j.dsp.2025.105264","volume":"164","author":"Qi Y.","year":"2025","unstructured":"Qi Y.; Cai J.; Chen R.; AO-TransUNet: A multi-attention optimization network for COVID-19 and medical image segmentation. Digit Signal Process  2025,164,105264","journal-title":"Digit Signal Process"}],"container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113895575407844251125060503","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/249921\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113895575407844251125060503","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:05:32Z","timestamp":1781064332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/249921\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113895575407844251125060503","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-05-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}